Bioproduction involves the growth and manipulation of large quantities of cells under tightly controlled conditions mandated by good manufacturing practices (GMP), while maintaining quality, reproducibility, and cost. Innovative technologies and strategies are being employed to optimize scale-up to high-throughput production. The Scientist brings together a panel of experts to discuss strategies and workflows for screening and optimizing cell lines for bioproduction. Attendees can interact with the panel during the live webinar by asking questions and sharing their experiences in cell line engineering.

Topics to be covered:

  • Genome-editing approaches for bioproduction
  • Analysis and leverage of screening and omics data to guide cell line engineering for biotherapeutic development

Meet the Speakers:

Dr. Jamie Freeman
Product Manager
Bioproduction
Horizon Discovery

 

Dr. Nathan Lewis
Assistant Professor
Department of Pediatrics
University of California, San Diego

 

Beckman Coulter

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?